Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver disease in pregnancy.

V K Rustgi1

  • 1Georgetown University School of Medicine, Washington, DC.

The Medical Clinics of North America
|July 1, 1989
PubMed
Summary

Pregnancy can involve various liver diseases, some unique to gestation like intrahepatic cholestasis and fatty liver. Prompt diagnosis of these conditions is crucial for maternal and fetal health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Alimentary pharmacology & therapeutics·2015
Same author

Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.

Alimentary pharmacology & therapeutics·2007
Same author

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.

Journal of viral hepatitis·2007
Same author

Impact of donor age on graft survival among liver transplant recipients: analysis of the United Network for Organ Sharing database.

Transplantation proceedings·2002
Same author

Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease.

Alimentary pharmacology & therapeutics·2002
Same author

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Lancet (London, England)·2001

Area of Science:

  • Hepatology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Liver diseases encompass a broad range of conditions that can manifest during pregnancy.
  • Understanding the spectrum of hepatic disorders in pregnant individuals is essential for effective management.
  • Differentiating between pregnancy-specific and coincidental liver conditions is clinically significant.

Purpose of the Study:

  • To review the spectrum of liver diseases encountered during pregnancy.
  • To highlight liver disorders uniquely associated with pregnancy.
  • To emphasize the importance of early recognition for improved outcomes.

Main Methods:

  • Literature review of hepatic disorders in pregnancy.
  • Categorization of liver diseases into pregnancy-associated and coincidental.
  • Discussion of key clinical features and diagnostic considerations.

Main Results:

  • Viral hepatitis is the most frequent cause of jaundice in pregnancy.
  • Intrahepatic cholestasis and fatty liver are liver conditions peculiar to pregnancy.
  • Early identification of these pregnancy-related liver diseases can be life-saving.

Conclusions:

  • Pregnant individuals are susceptible to the full spectrum of liver diseases.
  • Specific liver conditions like intrahepatic cholestasis and fatty liver require specialized attention during pregnancy.
  • Timely diagnosis and management of liver diseases in pregnancy are critical for patient survival.

Related Experiment Videos